Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, X-Linked

Explore clinical trials studying Genetic Diseases, X-Linked. Study availability and eligibility vary by location and protocol.

1,243 public trials 227 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, X-Linked trial results

Completed

Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies

NCT01126697

Conditions
Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, +11 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital Chicago, Illinois, United States
  • Carolinas Medical Center Charlotte, North Carolina, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World

NCT01217255

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Universidade Estadual de Campinas, UNICAMP Campinas, São Paulo, Brazil
  • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo São Paulo, Brazil
  • Universidade Federal de São Paulo (UNIFESP) São Paulo, Brazil
  • The Hospital for Sick Children Toronto, Ontario, Canada
View Trial Details
Completed

MRI in Patients With Kennedy Disease

NCT02501395

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Copenhagen Neuromuscular Center Copenhagen, Denmark
View Trial Details
Completed

Gene Therapy for WAS

NCT01347346

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Hôpital Necker-Enfants Malades Paris, France
View Trial Details
Completed

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

NCT01395810

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site San Francisco, California, United States
  • Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
  • Novo Nordisk Investigational Site Jacksonville, Florida, United States
View all 49 locations
View Trial Details

Related conditions